Goldline Pharmaceutical Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	5.92	12.4	7.9	0.54	1.41
Cash & Short-Term Investments	5.92	12.4	7.9	0.54	1.41
Cash Growth	-52.21%	56.94%	1357.38%	-61.58%	42.44%
Accounts Receivable	161.28	106.93	96.22	86.27	86.91
Receivables	181.12	129.9	109.84	107.05	86.91
Inventory	62.12	67.77	74.91	53.7	54.61
Other Current Assets	11.32	23.43	2.36	6.94	34.15
Total Current Assets	260.48	233.5	195	168.23	177.07
Property, Plant & Equipment	26.49	28.37	33.65	24.67	20.96
Long-Term Investments	0.25	-	-	0.34	0.34
Other Intangible Assets	0.56	0.78	0.63	0.58	0.58
Long-Term Deferred Tax Assets	0.77	-	-	-	-
Other Long-Term Assets	0	0.16	0.07	0.07	3.58
Total Assets	288.71	262.8	229.35	193.88	202.53
Accounts Payable	18.51	20.57	16.44	8.68	15.94
Accrued Expenses	-	7.89	6.06	7.69	13.18
Short-Term Debt	76.99	56.5	57.26	49.55	44.22
Current Portion of Long-Term Debt	-	21.92	13.52	20.63	-
Current Income Taxes Payable	-	9.91	6.73	1.36	-
Other Current Liabilities	25.64	0.86	1.65	2.07	1.34
Total Current Liabilities	121.14	117.65	101.66	89.97	74.69
Long-Term Debt	14.63	31.93	40.52	38.11	58.91
Pension & Post-Retirement Benefits	8.25	6.6	5.74	4.61	-
Long-Term Deferred Tax Liabilities	-	0.89	0.56	0.09	-
Other Long-Term Liabilities	2.2	2.2	2.2	2.2	-
Total Liabilities	146.21	159.27	150.69	134.98	133.59
Common Stock	87.07	69	23	20	20
Additional Paid-In Capital	-	-	-	-	20
Retained Earnings	55.43	16.46	37.58	20.83	10.87
Total Common Equity	142.5	85.46	60.58	40.83	50.87
Shareholders' Equity	142.5	103.53	78.65	58.9	68.94
Total Liabilities & Equity	288.71	262.8	229.35	193.88	202.53
Total Debt	91.62	110.34	111.3	108.29	103.13
Net Cash (Debt)	-85.69	-97.95	-103.4	-107.75	-101.72
Net Cash Per Share	-12.43	-14.20	-17.23	-17.96	-16.97
Filing Date Shares Outstanding	6.89	6.9	6.9	6	6
Total Common Shares Outstanding	6.89	6.9	6.9	6	6
Working Capital	139.35	115.85	93.34	78.26	102.39
Book Value Per Share	20.70	12.39	8.78	6.81	8.48
Tangible Book Value	141.94	84.68	59.95	40.25	50.29
Tangible Book Value Per Share	20.61	12.27	8.69	6.71	8.38
Land	-	-	4.7	4.7	-
Machinery	-	21.92	20.55	14.6	-
Construction In Progress	-	-	4.48	-	-